Australian case managers' views about the impact of antipsychotic medication on mental health consumers

International Journal of Mental Health Nursing

Volumn 24, Issue 6, 2015, Pages 547-553

  Morrison, Paul ^a   Meehan, Tom ^b   Stomski, Norman J ^a  

^a MURDOCH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antipsychotic medication; Case managers; Qualitative; Side effects

Indexed keywords

NEUROLEPTIC AGENT;

AUSTRALIA; CASE MANAGER; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERVIEW; MALE; MEDICATION COMPLIANCE; MENTAL DISORDERS; PSYCHOLOGY;

ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; CASE MANAGERS; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICATION ADHERENCE; MENTAL DISORDERS;

EID: 84948580210     PISSN: 14458330     EISSN: 14470349     Source Type: Journal    
DOI: 10.1111/inm.12154     Document Type: Article

References (42)

1. Acosta, F. J., Bosch, E., Sarmiento, G., Juanes, N., Caballero-Hidalgo, A. & Mayans, T. (2009). Evaluation of noncompliance in schizophrenia patients using electronic monitoring (MEMS) and its relationship to sociodemographic, clinical and psychopathological variables. Schizophrenia Research, 107, 213-217.
2. Australian Human Rights Commission (1993). National Inquiry Concerning the Human Rights of People with Mental Illness. Canberra: Australian Government Publishing Service.
3. Australian Institute of Health and Welfare (2010). Mental Health Services in Australia 2007-08. Canberra, ACT: Australian Institute of Health and Welfare.
4. Berg, B. (2009). Qualitative Research Methods for the Social Sciences, 7th edn. Boston, Mass.: Allyn & Bacon.
5. Borg, M. & Kristiansen, K. (2004). Recovery oriented professionals: Helping relationships in mental health services. Journal of Mental Health, 13, 493-505.
6. Burnard, P. (1991). A method of analysing interview transcripts in qualitative research. Nurse Education Today, 11, 461-466.
7. Burnard, P. (1996). Teaching the analysis of textual data: An experiential approach. Nurse Education Today, 16, 278-281.
8. Calsyn, R. J., Klinkenberg, W. D., Morse, G. A. & Lemming, M. R. (2006). Predictors of the working alliance in assertive community treatment. Community Mental Health Journal, 42, 161-175.
9. Coombs, T., Deane, F. P., Lambert, G. & Griffiths, R. (2003). What influences patients' medication adherence? Mental health nurse perspectives and a need for education and training. International Journal of Mental Health Nursing, 12, 148-152.
10. Dolder, C. R., Lacro, J. P., Leckband, S. & Jeste, D. V. (2003). Interventions to improve antipsychotic medication adherence: Review of recent literature. Journal of Clinical Psychopharmacology, 23, 389-399.
11. Gray, R., Wykes, T. & Gournay, K. (2002). From compliance to concordance: A review of the literature on interventions to enhance compliance with antipsychotic medication. Journal of Psychiatric and Mental Health Nursing, 9, 277-284.
12. Haddad, P. M. & Sharma, S. G. (2007). Adverse effects of atypical antipsychotics: Differential risk and clinical implications. CNS Drugs, 21, 911-936.
13. Haddad, P. M., Brain, C. & Scott, J. (2014). Nonadherence with antipsychotic medication in schizophrenia: Challenges and management strategies. Patient Related Outcome Measures, 5, 43-62.
14. Happell, B. (2008). Putting all the pieces together: Exploring workforce issues in mental health nursing. Contemporary Nurse: A Journal for the Australian Nursing Profession, 29, 43-52.
15. Happell, B., Manias, E. & Roper, C. (2004). Wanting to be heard: Mental health consumers' experiences of information about medication. International Journal of Mental Health Nursing, 13, 242-248.
16. Happell, B., Hoey, W. & Gaskin, C. J. (2012). Community mental health nurses, caseloads, and practices: A literature review. International Journal of Mental Health Nursing, 21, 131-137.
17. Henderson, J., Willis, E., Walter, B. & Toffoli, L. (2008). Community mental health nursing: keeping pace with care delivery? International Journal of Mental Health Nursing, 17, 162-170.
18. Howard, P. B., El-Mallakh, P., Miller, A. L. etal. (2009). Fidelity to a medication management evidence-based practice in the treatment of schizophrenia. Psychiatric Services (Washington, D.C.), 60, 929-935.
19. Howgego, I. M., Yellowlees, P., Owen, C., Meldrum, L. & Dark, F. (2003). The therapeutic alliance: The key to effective patient outcome? A descriptive review of the evidence in community mental health case management. The Australian and New Zealand Journal of Psychiatry, 37, 169-183.
20. Jacobs, S., Hughes, J., Challis, D., Stewart, K. & Weiner, K. (2006). Care managers' time use: Differences between community mental health and older people's services in the United Kingdom. Care Management Journals: Journal of Case Management; the Journal of Long Term Home Health Care, 7, 169-178.
21. de Leeuw, M., Van Meijel, B., Grypdonck, M. & Kroon, H. (2012). The quality of the working alliance between chronic psychiatric patients and their case managers: Process and outcomes. Journal of Psychiatric and Mental Health Nursing, 19, 1-7.
22. Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C. & Davis, J. M. (2009). Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet, 373, 31-41.
23. Lieberman, J. A., Stroup, T. S., McEvoy, J. P. etal. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. The New England Journal of Medicine, 353, 1209-1223.
24. Loffler, W., Kilian, R., Toumi, M. & Angermeyer, M. C. (2003). Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry, 36, 105-112.
25. Lysaker, P. H., Vohs, J., Hillis, J. D. etal. (2013). Poor insight into schizophrenia: Contributing factors, consequences and emerging treatment approaches. Expert Review of Neurotherapeutics, 13, 785-793.
26. McCabe, R. & Priebe, S. (2004). The therapeutic relationship in the treatment of severe mental illness: A review of methods and findings. The International Journal of Social Psychiatry, 50, 115-128.
27. Morrison, P. & Stomski, N. J. (2015). Embracing participation in mental health research: Conducting authentic interviews. Qualitative Research Journal, 15, 47-60.
28. Morrison, P., Meehan, T., Gaskill, D., Lunney, P. & Collings, P. (2000). Enhancing case managers' skills in the assessment and management of antipsychotic medication side-effects. The Australian and New Zealand Journal of Psychiatry, 34, 814-821.
29. Morrison, P., Meehan, T. & Stomski, N. J. (2015a). Living with antipsychotic medication side-effects: the experience of Australian mental health consumers. International Journal of Mental Health Nursing, 24, 253-261. doi: 10.1111/inm.12110.
30. Morrison, P., Meehan, T. & Stomski, N. J. (2015b). Australian case managers' perceptions of mental health consumers use of antipsychotic medications and associated side-effects. International Journal of Mental Health Nursing, 24, 104-111. doi: 10.1111/inm.12118.
31. National Institute for Health and Clinical Excellence (2009). Medicines adherence involving patients in decisions about prescribed medicines and supporting adherence [Online]. [Cited 1/8 2014]. Available from URL: http://www.nice.org.uk/guidance/CG76
32. Neale, M. S. & Rosenheck, R. A. (2000). Therapeutic limit setting in an assertive community treatment program. Psychiatric Services (Washington, D.C.), 51, 499-505.
33. Ng, D. T., Chan, S. W. & Mackenzie, A. (2000). Case management in the Community Psychiatric Nursing Service in Hong Kong: Describing the process. Perspectives in Psychiatric Care, 36, 59-66.
34. Pekkala, E. & Merinder, L. (2002). Psychoeducation for schizophrenia. Cochrane Database of Systematic Reviews, (2), CD002831.
35. Prince, J. D. (2007). Therapeutic alliance, illness awareness, and number of hospitalizations for schizophrenia. The Journal of Nervous and Mental Disease, 195, 170-174.
36. Simpson, A. (2005). Community psychiatric nurses and the care co-ordinator role: Squeezed to provide 'limited nursing'. Journal of Advanced Nursing, 52, 689-699.
37. Suttajit, S., Srisurapanont, M., Xia, J., Suttajit, S., Maneeton, B. & Maneeton, N. (2013). Quetiapine versus typical antipsychotic medications for schizophrenia. Cochrane Database of Systematic Reviews, (5), CD007815. doi:10.1002/14651858.CD007815.pub2
38. Tardy, M., Dold, M., Engel, R. R. & Leucht, S. (2014). Flupenthixol versus low-potency first-generation antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews, (9), CD009227. doi:10.1002/14651858.CD009227.pub2
39. Velligan, D. I., Weiden, P. J., Sajatovic, M. etal. (2009). The expert consensus guideline series: Adherence problems in patients with serious and persistent mental illness. The Journal of Clinical Psychiatry, 70 (Suppl. 4), 1-46. quiz 47-48.
40. Wallace, T., O'connell, S. & Frisch, S. R. (2005). What do nurses do when they take to the streets? An analysis of psychiatric and mental health nursing interventions in the community. Community Mental Health Journal, 41, 481-496.
41. Wilder, C. M., Elbogen, E. B., Moser, L. L., Swanson, J. W. & Swartz, M. S. (2010). Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives. Psychiatric Services (Washington, D.C.), 61, 380-385.
42. Williams, G. C., Rodin, G. C., Ryan, R. M., Grolnick, W. S. & Deci, E. L. (1998). Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychology, 17, 269-276.